Dr Reddy's Lines Up Rs 1,000 Cr Capex For Current Fiscal

The drug maker's growth would be primarily driven by organic moves, focusing around pipeline monetisation, productivity enhancement, diversifications and capability ramp-up in marketing and digitalisation